市场调查报告书
商品编码
1470779
电生理学市场:按产品、适应症和最终用户划分 - 全球预测 2024-2030Electrophysiology Market by Product, Indication, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年电生理学市场规模为1.9764亿美元,预计2024年将达2.2357亿美元,2030年将达4.8205亿美元,复合年增长率为13.58%。
电生理学是生理学的一个分支,重点是活细胞和组织的电特性。电生理学市场涵盖用于诊断和治疗心臟电活动的设备和技术的研究、开发、製造和销售的各个方面。这包括心电图 (ECG)、电生理学研究 (EPS) 和消融设备等诊断测试。心房颤动的增加和对心导管电气烧灼术的偏好正在推动市场成长。对微创治疗的需求不断增长也在市场扩张中发挥重要作用。手术和设备高成本、缺乏熟练的专业人员以及定义鬆散的医疗改革是影响电生理学市场的限制因素。电生理学设备的技术进步以及电生理学中 3D 绘图系统的引入预计将为电生理学市场带来重大商机。
主要市场统计 | |
---|---|
基准年[2023] | 1.9764亿美元 |
预测年份 [2024] | 22357万美元 |
预测年份 [2030] | 4.8205亿美元 |
复合年增长率(%) | 13.58% |
由于产品的高精度和详细的测绘能力,对高密度测绘导管的需求正在增加
在电生理学 (EP) 中,接取装置是一种进入血管进行诊断或治疗的仪器。包括导引鞘、导管导引线等,有助于将导管插入和引导至心臟。电生理消融导管是用于消融或破坏引起心律不整的小面积心臟组织的专用仪器。我们使用多种能源来源,包括射频、冷冻疗法和雷射。冷冻消融导管是一种专门的电生理学设备,它使用极低的温度来惰性心臟组织并恢復正常的心律。此过程通常使用低温物质(例如液态氮或氧化亚氮)来去除问题区域。在电生理学中,雷射消熔系统用于以最小的附带损伤进行精确消融。雷射发出单色光能,被目标组织吸收,导致温度升高并随后破坏组织。微波消融系统使用微波频率的电磁波在心臟组织内产生热。这种热量会导致凝固性坏死,有效地消除异常电活动的根源。用于导航的先进测绘附件有助于复杂的消融手术。这些设备,包括标测导管和软体,可以在心室内进行精确的可视化和导航。射频 (RF) 消融导管是心导管电气烧灼术治疗的标准工具。射频导管将射频能源传送到导管尖端加热组织并引起局部消融。
诊断电生理学导管用于绘製心臟的电活动图,以确定心律不整的原因。它们有各种形状和尺寸,以满足不同的解剖学要求。先进的电气生理学诊断导管是用于绘製和分析心臟电活动的最先进工具。这些高度敏感的导管提供即时资料,能够精确定位心律不整发作部位。传统的电气生理学诊断导管一直是心律不整研究的基石。这些导管比更先进的导管简单,用于心臟电导的基本绘图。超音波电气生理学诊断导管采用心内回波 (ICE) 技术,可提供心臟内部即时、高解析度的影像。这些导管使用超音波来可视化心臟的结构和血流,帮助评估复杂的心律不整并指导介入手术。
EP 测试设备包括多种设备,例如测绘和记录系统、消融产生器和心内回波系统。这些测试设备对于所有电生理学程序的成功至关重要。 3D 绘图系统是 EP 实验室使用的先进工具,用于即时创建心室的3D模型。使用这个模型,医生可以高精度地可视化和导航心臟的结构,从而可以精确绘製心律不整期间的电活动并指导治疗性介入,包括消融手术。电生理学记录系统是 EP 实验室的基础技术,提供了测量和记录心臟内电讯号的方法。电生理学远端控制系统使用先进的磁性和机器人技术,使医生能够远端控制心臟内的导管和其他设备。 X 光影像在 EP 实验室中非常重要,可以在手术过程中可视化导管放置和解剖结构。萤光镜检查系统通常由萤光镜组成,该萤光镜提供即时影像以引导导管和其他器械在心臟脉管系统内的移动。超音波心动图 (ICE) 系统是 EP 实验室使用的专门超音波测试。 ICE 涉及将超音波探头穿过脉管系统并进入心臟,提供心臟结构的详细影像。这在经导管介入和电生理学研究等手术过程中特别有用。射频消融术(RFA) 产生器是 EP 实验室使用的一种设备,可将射频能源施加到心臟组织以治疗心律不整。这种能量产生热量并导致组织有针对性的破坏,从而导致异常的电途径。
最终用户:由于需要在更私密和专业的环境中接受优质护理,门诊手术中心 (ASC) 变得越来越受欢迎。
由于其成本效益和效率,门诊手术中心 (ASC) 越来越成为电生理手术的首选。 ASC 的等待时间短且流程简化,使其成为患者和提供者的便捷选择。在电生理学市场中,医院和心臟中心是传统的主导参与者。这些中心通常提供更全面的服务,因为它们拥有更大的基础设施和资源,包括专业人员、先进的技术以及处理复杂案件和紧急情况的能力。这些中心提供广泛的电生理学服务,包括诊断和治疗程序,并优先考虑综合护理。对 ASC 和医院/心臟中心的分析表明,ASC 由于其便利、高效和低成本而正在迅速增长,这使得它们对需要常规手术的患者俱有吸引力。 ASC 提供高标准的患者客製化护理,週转时间短,可最大限度地降低成本。另一方面,选择医院和心臟中心是因为它们有能力处理更复杂和多样化的病例。
区域洞察
美洲电生理学市场的特点是技术先进,包括强大的医疗基础设施、大量的研发投资以及大量市场参与者的存在。由于人口老化和与生活方式相关的心臟病的增加,消融和诊断等电生理手术的采用越来越多。巴西和阿根廷等国家在该地区处于领先地位,因为它们改善了医疗保健设施,提高了对心律不整疾病的认识,并改善了经济状况,增加了获得先进医疗服务的机会。由于医疗保健支出增加、慢性病盛行率上升以及老年人口不断增加,亚太地区预计将成为全球成长最快的电生理学市场。中国、日本和印度等国家走在了前列,各国政府开始进行改革,以改善医疗保健的可近性并加速先进医疗技术的采用。由于高昂的医疗保健成本、完善的医疗保健系统以及日益增加的心臟疾病患病率,欧洲是欧洲、中东和非洲电生理学市场的重要贡献者。技术进步和有利的报销政策也支持该地区的市场成长。在经济状况改善和政府医疗基础设施现代化倡议的推动下,中东和非洲是潜力开拓的新兴地区。
FPNV定位矩阵
FPNV定位矩阵对于评估电生理学市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对电生理学市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,以获得市场竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争力评估及资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1. 电生理学市场的市场规模与预测是多少?
2.在电生理学市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3. 电生理学市场的技术趋势和法规结构是什么?
4.电生理市场主要厂商的市场占有率是多少?
5. 进入电生理学市场合适的型态和策略手段是什么?
需要在更亲密和专业的环境中提供优质护理
[193 Pages Report] The Electrophysiology Market size was estimated at USD 197.64 million in 2023 and expected to reach USD 223.57 million in 2024, at a CAGR 13.58% to reach USD 482.05 million by 2030.
Electrophysiology is a branch of physiology that focuses on the study of the electrical properties of biological cells and tissues. The electrophysiology market encompasses all aspects of the research, development, manufacturing, and sale of devices and technologies used for the diagnosis and treatment of electrical activities of the heart. This includes diagnostic tests such as electrocardiograms (ECG), electrophysiological studies (EPS), and ablation devices. Increasing incidences of atrial fibrillation and preference for electrophysiology catheter ablation drive the market growth. Growing demand for minimally invasive procedures also plays a significant role in market expansion. The high cost of procedures and equipment, shortage of skilled professionals, and loosely defined healthcare reforms are among the limitations affecting the electrophysiology market. Technological advancements in electrophysiology devices and the Introduction of 3D mapping systems in electrophysiology are expected to create significant opportunities for the electrophysiology market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 197.64 million |
Estimated Year [2024] | USD 223.57 million |
Forecast Year [2030] | USD 482.05 million |
CAGR (%) | 13.58% |
Product: Growing demand for high-density mapping catheters due to their enhanced precision and detailed mapping capabilities
Access devices in electrophysiology (EP) are tools that grant entry into vascular spaces to perform diagnostic or therapeutic procedures. They include introducer sheaths, guide wires, and other devices facilitating the insertion and guidance of catheters into the heart. Electrophysiology ablation catheters are specialized instruments used to ablate or destroy small areas of heart tissue that cause arrhythmias. They employ various energy sources such as radiofrequency, cryotherapy, or laser. Cryoablation catheters are specialized electrophysiology devices that utilize extreme cold temperatures to inactivate cardiac tissue and restore normal heart rhythm. The process involves using a cryogenic substance, typically liquid nitrogen or nitrous oxide, to ablate the problematic areas. Laser ablation systems are used in electrophysiology for precise ablation with minimal collateral damage. They deliver monochromatic light energy absorbed by the targeted tissue, causing a rise in temperature and subsequent tissue destruction. Microwave ablation systems use electromagnetic waves at microwave frequencies to generate heat within cardiac tissues. This heat causes coagulative necrosis, effectively eliminating the source of abnormal electrical activity. Navigational advanced mapping accessories are instrumental in complex ablation procedures. These devices, including mapping catheters and software, enable precise visualization and navigation within the heart's chambers. Radiofrequency (RF) ablation catheters are the standard tools for catheter ablation treatments. They work by emitting radiofrequency energy to heat tissue at the catheter's tip, causing focal ablation.
Diagnostic catheters in electrophysiology are designed for mapping the heart's electrical activity to identify sources of arrhythmia. They come in various shapes and sizes for different anatomical requirements. Advanced electrophysiology diagnostic catheters are state-of-the-art tools used to map and analyze electrical activity in the heart. These highly sensitive catheters provide real-time data, allowing for the precise localization of arrhythmogenic sites. Conventional electrophysiology diagnostic catheters have been the cornerstone for studying cardiac arrhythmias. They are less complex than advanced models and are used for the basic mapping of the heart's electrical conductance. Ultrasound electrophysiology diagnostic catheters incorporate intracardiac echocardiography (ICE) technology to provide real-time, high-resolution imaging inside the heart. These catheters use ultrasound waves to visualize cardiac structures and blood flow, which aids in the assessment of complex arrhythmias and in guiding interventional procedures.
EP laboratory devices encompass a range of equipment, including mapping and recording systems, ablation generators, and intracardiac echocardiography systems. These laboratory devices are integral for the success of all electrophysiology procedures. A 3D mapping system is a sophisticated tool used in an EP lab to create a real-time, three-dimensional model of the heart's chambers. Utilizing this model, physicians can visualize and navigate cardiac structures with a high level of accuracy, allowing for precise electrical activity mapping during arrhythmias and guidance of therapeutic interventions, including ablation procedures. The electrophysiology recording system serves as the foundational technology in an EP lab, providing the means to measure and record the electrical signals within the heart. Electrophysiology remote steering systems allow physicians to control catheters and other devices within the heart remotely using advanced magnetic or robotic technology. X-ray imaging is critical in the EP lab for visualizing catheter placement and anatomy during procedures. An electrophysiology X-ray system typically comprises fluoroscopy equipment, which provides real-time imaging to guide the movement of catheters and other devices within the heart's vascular system. An intracardiac echocardiography (ICE) system is a specialized form of ultrasound used within the EP lab. ICE involves threading an ultrasound probe into the heart through the vascular system to provide detailed images of heart structures. This is especially useful during procedures such as transcatheter interventions and electrophysiological studies. The radiofrequency ablation (RFA) generator is a device used in the EP lab to treat arrhythmias by applying radiofrequency energy to the heart tissue. This energy generates heat, causing targeted destruction of tissue responsible for the abnormal electrical pathways.
End-User: Rising popularity of ambulatory surgery centers (ASCs) due to the need for high-quality care in a more intimate and specialized setting
Ambulatory surgery centers (ASCs) have been increasingly preferred for electrophysiological procedures due to their cost-effectiveness and efficiency. ASCs offer a convenient alternative for both patients and healthcare providers with shorter wait times and streamlined processes. Hospitals and cardiac centers are the traditional and dominant players in the electrophysiology market. They typically offer more comprehensive services due to their larger infrastructure and resources, including specialized staff, advanced technology, and the capacity to handle complex cases and emergencies. These centers prioritize integrated care with a wide spectrum of electrophysiological services, including both diagnostic and therapeutic procedures. In analyzing ASCs and hospitals & cardiac centers, ASCs are growing rapidly due to their convenience, efficiency, and lower costs, making them attractive for patients requiring routine procedures. They are often chosen for their high standard of personalized patient care and quick turnover times, which aids in cost minimization. Hospitals and cardiac centers, on the other hand, are selected for their ability to manage more complex and diverse cases.
Regional Insights
The electrophysiology market in the Americas is characterized by technological advancements with a robust healthcare infrastructure, substantial R&D investments, and the presence of majority market players. The adoption of electrophysiology procedures such as ablation and diagnostics is increasing due to the aging population and the rise in lifestyle-related cardiac issues. Countries such as Brazil and Argentina are leading in this region due to improving healthcare facilities, increasing awareness of arrhythmia conditions, and an upshift in the economic conditions, allowing for better access to advanced healthcare. The Asia-Pacific region is projected to be the growing electrophysiology market globally, attributed to increasing healthcare expenditure, rising incidence of chronic diseases, and an expanding geriatric population. Countries such as China, Japan, and India are at the forefront, with governments initiating reforms to improve healthcare access and promote the adoption of advanced medical technologies. Europe significantly contributes to the EMEA electrophysiology market, driven by higher healthcare spending, a well-established healthcare system, and an increasing prevalence of cardiac diseases. Technological advancements and favorable reimbursement policies also support the market growth within this region. The Middle East and Africa are emerging with untapped potential, subject to improving economic conditions and government initiatives to modernize healthcare infrastructure.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Electrophysiology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Electrophysiology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Electrophysiology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Access Point Technologies EP, Inc., AccuPulse Medical Technology Co. Ltd., AtriCure, Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, CardioFocus, Inc., CathRx Ltd, Diagnosys LLC, ElectroPhysiology Frontiers S.p.A., GE HealthCare Technologies Inc., Imricor Medical Systems, Inc., Japan Lifeline Co., Ltd., Judges Scientific PLC, Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co., Ltd., Medical Device Business Services, Inc., Medtronic, Inc., Melys AFS Ltd, Microport Scientific Corporation, Nihon Kohden Corporation, Osypka AG, Siemens Healthcare GmbH, Teleflex Incorporated, and Warner Instruments, LLC.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Electrophysiology Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Electrophysiology Market?
3. What are the technology trends and regulatory frameworks in the Electrophysiology Market?
4. What is the market share of the leading vendors in the Electrophysiology Market?
5. Which modes and strategic moves are suitable for entering the Electrophysiology Market?
the need for high-quality care in a more intimate and specialized setting